Carotuximab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Carotuximab, covering 2020-05-12 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer [Phase 1]